Niemann-Pick Disease, Type C
"Niemann-Pick Disease, Type C" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An autosomal recessive lipid storage disorder that is characterized by accumulation of CHOLESTEROL and SPHINGOMYELINS in cells of the VISCERA and the CENTRAL NERVOUS SYSTEM. Type C (or C1) and type D are allelic disorders caused by mutation of gene (NPC1) encoding a protein that mediate intracellular cholesterol transport from lysosomes. Clinical signs include hepatosplenomegaly and chronic neurological symptoms. Type D is a variant in people with a Nova Scotia ancestry.
MeSH Number(s)
C10.228.140.163.100.435.825.700.875
C15.604.250.410.625.875
C16.320.565.189.435.825.700.875
C16.320.565.398.641.803.730.875
C16.320.565.595.554.825.700.875
C18.452.132.100.435.825.700.875
C18.452.584.687.803.730.875
C18.452.648.189.435.825.700.875
C18.452.648.398.641.803.730.875
C18.452.648.595.554.825.700.875
Concept/Terms
Niemann-Pick Disease, Type C- Niemann-Pick Disease, Type C
- Niemann Pick Disease, Type C
- Niemann-Pick's Disease Type C
- Niemann Pick's Disease Type C
- Niemann-Pick Disease without Sphingomyelinase Deficiency
- Niemann Pick Disease without Sphingomyelinase Deficiency
- Niemann-Pick Disease, Chronic Neuronopathic Form
- Niemann Pick Disease, Chronic Neuronopathic Form
- Neurovisceral Storage Disease with Vertical Supranuclear Ophthalmoplegia
- Niemann-Pick Disease with Cholesterol Esterification Block
- Niemann Pick Disease with Cholesterol Esterification Block
Niemann-Pick Disease, Type C1- Niemann-Pick Disease, Type C1
- Niemann-Pick disease, Subacute Juvenile Form
- Niemann Pick disease, Subacute Juvenile Form
Niemann-Pick Disease, Type D- Niemann-Pick Disease, Type D
- Niemann Pick Disease, Type D
- Nova Scotia Niemann-Pick Disease (Type D)
- Nova Scotia Niemann Pick Disease (Type D)
- Niemann-Pick's Disease Type D
- Niemann Pick's Disease Type D
- Nova Scotia (Type D) Form of Niemann-Pick Disease
- Niemann-Pick Disease Type D
- Niemann Pick Disease Type D
- Niemann-Pick Disease, Nova Scotian
- Niemann Pick Disease, Nova Scotian
Below are MeSH descriptors whose meaning is more general than "Niemann-Pick Disease, Type C".
- Diseases [C]
- Nervous System Diseases [C10]
- Central Nervous System Diseases [C10.228]
- Brain Diseases [C10.228.140]
- Brain Diseases, Metabolic [C10.228.140.163]
- Brain Diseases, Metabolic, Inborn [C10.228.140.163.100]
- Lysosomal Storage Diseases, Nervous System [C10.228.140.163.100.435]
- Sphingolipidoses [C10.228.140.163.100.435.825]
- Niemann-Pick Diseases [C10.228.140.163.100.435.825.700]
- Niemann-Pick Disease, Type C [C10.228.140.163.100.435.825.700.875]
- Hemic and Lymphatic Diseases [C15]
- Lymphatic Diseases [C15.604]
- Histiocytosis [C15.604.250]
- Histiocytosis, Non-Langerhans-Cell [C15.604.250.410]
- Niemann-Pick Diseases [C15.604.250.410.625]
- Niemann-Pick Disease, Type C [C15.604.250.410.625.875]
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Genetic Diseases, Inborn [C16.320]
- Metabolism, Inborn Errors [C16.320.565]
- Brain Diseases, Metabolic, Inborn [C16.320.565.189]
- Lysosomal Storage Diseases, Nervous System [C16.320.565.189.435]
- Sphingolipidoses [C16.320.565.189.435.825]
- Niemann-Pick Diseases [C16.320.565.189.435.825.700]
- Niemann-Pick Disease, Type C [C16.320.565.189.435.825.700.875]
- Lipid Metabolism, Inborn Errors [C16.320.565.398]
- Lipidoses [C16.320.565.398.641]
- Sphingolipidoses [C16.320.565.398.641.803]
- Niemann-Pick Diseases [C16.320.565.398.641.803.730]
- Niemann-Pick Disease, Type C [C16.320.565.398.641.803.730.875]
- Lysosomal Storage Diseases [C16.320.565.595]
- Lysosomal Storage Diseases, Nervous System [C16.320.565.595.554]
- Sphingolipidoses [C16.320.565.595.554.825]
- Niemann-Pick Diseases [C16.320.565.595.554.825.700]
- Niemann-Pick Disease, Type C [C16.320.565.595.554.825.700.875]
- Nutritional and Metabolic Diseases [C18]
- Metabolic Diseases [C18.452]
- Brain Diseases, Metabolic [C18.452.132]
- Brain Diseases, Metabolic, Inborn [C18.452.132.100]
- Lysosomal Storage Diseases, Nervous System [C18.452.132.100.435]
- Sphingolipidoses [C18.452.132.100.435.825]
- Niemann-Pick Diseases [C18.452.132.100.435.825.700]
- Niemann-Pick Disease, Type C [C18.452.132.100.435.825.700.875]
- Lipid Metabolism Disorders [C18.452.584]
- Lipidoses [C18.452.584.687]
- Sphingolipidoses [C18.452.584.687.803]
- Niemann-Pick Diseases [C18.452.584.687.803.730]
- Niemann-Pick Disease, Type C [C18.452.584.687.803.730.875]
- Metabolism, Inborn Errors [C18.452.648]
- Brain Diseases, Metabolic, Inborn [C18.452.648.189]
- Lysosomal Storage Diseases, Nervous System [C18.452.648.189.435]
- Sphingolipidoses [C18.452.648.189.435.825]
- Niemann-Pick Diseases [C18.452.648.189.435.825.700]
- Niemann-Pick Disease, Type C [C18.452.648.189.435.825.700.875]
- Lipid Metabolism, Inborn Errors [C18.452.648.398]
- Lipidoses [C18.452.648.398.641]
- Sphingolipidoses [C18.452.648.398.641.803]
- Niemann-Pick Diseases [C18.452.648.398.641.803.730]
- Niemann-Pick Disease, Type C [C18.452.648.398.641.803.730.875]
- Lysosomal Storage Diseases [C18.452.648.595]
- Lysosomal Storage Diseases, Nervous System [C18.452.648.595.554]
- Sphingolipidoses [C18.452.648.595.554.825]
- Niemann-Pick Diseases [C18.452.648.595.554.825.700]
- Niemann-Pick Disease, Type C [C18.452.648.595.554.825.700.875]
Below are MeSH descriptors whose meaning is more specific than "Niemann-Pick Disease, Type C".
This graph shows the total number of publications written about "Niemann-Pick Disease, Type C" by people in Harvard Catalyst Profiles by year, and whether "Niemann-Pick Disease, Type C" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2013 | 1 | 1 | 2 |
| 2014 | 1 | 0 | 1 |
| 2015 | 3 | 0 | 3 |
| 2016 | 4 | 0 | 4 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 2 | 3 |
| 2019 | 5 | 0 | 5 |
| 2020 | 3 | 0 | 3 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
Below are the most recent publications written about "Niemann-Pick Disease, Type C" by people in Profiles.
-
Intravenous 2-hydroxypropyl-ß-cyclodextrin (Trappsol® Cyclo™) demonstrates biological activity and impacts cholesterol metabolism in the central nervous system and peripheral tissues in adult subjects with Niemann-Pick Disease Type C1: Results of a phase 1 trial. Mol Genet Metab. 2022 Dec; 137(4):309-319.
-
The CD22-IGF2R interaction is a therapeutic target for microglial lysosome dysfunction in Niemann-Pick type C. Sci Transl Med. 2021 12; 13(622):eabg2919.
-
Estimating the prevalence of Niemann-Pick disease type C (NPC) in the United States. Mol Genet Metab. 2021 Sep-Oct; 134(1-2):182-187.
-
Application of a glycinated bile acid biomarker for diagnosis and assessment of response to treatment in Niemann-pick disease type C1. Mol Genet Metab. 2020 12; 131(4):405-417.
-
Potential COVID-19 therapeutics from a rare disease: weaponizing lipid dysregulation to combat viral infectivity. J Lipid Res. 2020 07; 61(7):972-982.
-
Imaging of neuroinflammation in adult Niemann-Pick type C disease: A cross-sectional study. Neurology. 2020 04 21; 94(16):e1716-e1725.
-
Application of N-palmitoyl-O-phosphocholineserine for diagnosis and assessment of response to treatment in Niemann-Pick type C disease. Mol Genet Metab. 2020 04; 129(4):292-302.
-
The Palliative Use of Intrathecal Baclofen in Niemann-Pick Disease Type C. Pediatrics. 2019 11; 144(5).
-
Ocular motor manifestations of movement disorders. Curr Opin Ophthalmol. 2019 Nov; 30(6):443-448.
-
Expanded access with intravenous hydroxypropyl-ß-cyclodextrin to treat children and young adults with Niemann-Pick disease type C1: a case report analysis. Orphanet J Rare Dis. 2019 10 21; 14(1):228.